Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Non-interventional Real-world Study Assessing the Effectiveness of Extrafine BDP/FF/G (Beclometasone Dipropionate/Formoterol Fumarate/Glycopyrronium) 172/5/9 mcg, (Pressurised Inhalation, Solution) Single Inhaler Triple Therapy (SITT) on Symptom Scores in Asthma Patients After 6 Months Treatment

NCT06786767 is registered in ClinicalTrials.gov with Chiesi Bulgaria as lead sponsor.

NCT NCT06786767
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06786767 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Non-interventional Real-world Study Assessing the Effectiveness of Extrafine BDP/FF/G (Beclometasone Dipropionate/Formoterol Fumarate/Glycopyrronium) 172/5/9 mcg, (Pressurised Inhalation, Solution) Single Inhaler Triple Therapy (SITT) on Symptom Scores in Asthma Patients After 6 Months Treatment
Lead sponsor
Chiesi Bulgaria
Phase
Observational
Overall status
Completed
Start date
February 1, 2025
Completion date
January 5, 2026
Enrollment
281 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

asthma, asthma bronchiale, asthma patients